Acceptance and Completion Rate of Free HPV Vaccination Among Underserved Adult Patients (Age 18-45)

Who is this study for? Patients with Human Papillomavirus (HPV) Infection
What treatments are being studied? Educational Intervention+Survey Administration
Status: Active_not_recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

This phase IV trial examines the impact of an education program on the human papilloma virus (HPV) and its effects on the acceptance and completion rates of a free HPV vaccination program in underserved adult patients. Participating in the HPV educational program may increase the HPV vaccination rates among low income uninsured adult patients and ultimately prevent HPV related cancers.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• Male and female adults patients seen at Volunteers in Medicine ages 18-45 years of age who read and understand English or Spanish

Locations
United States
Florida
Mayo Clinic in Florida
Jacksonville
Time Frame
Start Date: 2020-10-19
Completion Date: 2025-12-22
Participants
Target number of participants: 100
Treatments
Experimental: Prevention (HPV educational program)
Patients receive educational materials on HPV and are asked of their willingness to proceed with the first HPV vaccination. Patients who express interest in receiving the HPV vaccination, then receive the first dose of the HPV vaccine and the next 2 doses approximately 2 months and 6 months following the initial vaccine.
Related Therapeutic Areas
Sponsors
Leads: Mayo Clinic

This content was sourced from clinicaltrials.gov